Y. Saijo

发表

A. Gemma, Tomoaki Tanaka, S. Morita, 2010 .

Generation of Lungs by Blastocyst Complementation in Apneumic Fgf10-Deficient Mice.

K. Sakimura, Y. Ajioka, A. Yasue, 2020, Cell reports.

Contiguous Four‐guanosine Sequence in c‐myc Antisense Phosphorothioate Oligonucleotides Inhibits Cell Growth on Human Lung Cancer Cells: Possible Involvement of Cell Adhesion Inhibition

T. Abe, T. Nukiwa, Y. Saijo, 1997, Japanese journal of cancer research : Gann.

Cancers among adolescents and young adults at one institution in Japan

Y. Saijo, Y. Matsumoto, Qiliang Zhou, 2018, Oncology letters.

First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy.

A. Gemma, Tomoaki Tanaka, S. Morita, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung Cancer

Y. Nakanishi, K. Takayama, T. Sasada, 2016, Journal of immunology research.

Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402.

F. Hommura, K. Yamazaki, M. Maemondo, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multicenter phase I study of repeated intratumoral delivery of adenoviral p53 in patients with advanced non-small-cell lung cancer.

H. Kato, S. Kanazawa, T. Fujiwara, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Successful treatment of carcinomatous meningitis with gefitinib in a patient with lung adenocarcinoma harboring a mutated EGF receptor gene.

T. Nukiwa, A. Inoue, Y. Saijo, 2008, The Tohoku journal of experimental medicine.

Non-Small Cell Lung Cancer Promoter-Controlled Replication-Competent Adenovirus for Gene Therapy with Secretory Leukoprotease Inhibitor

Y. Niitsu, Toshikazu Nakamura, M. Maemondo, 2004 .

Gene Therapy with Secretory Leukoprotease Inhibitor Promoter-Controlled Replication-Competent Adenovirus for Non-Small Cell Lung Cancer

Y. Niitsu, Toshikazu Nakamura, M. Maemondo, 2004, Cancer Research.

Sequential irinotecan hydrochloride/S-1 for S-1-resistant inoperable gastric cancer: A feasibility study.

H. Tohno, T. Satoh, Y. Sakata, 2012, Oncology letters.

Chromosomal rearrangements in myoepithelial carcinoma of the breast that presented as metachronic double cancer with invasive ductal carcinoma in the ipsilateral breast.

A. Ogose, H. Umezu, N. Endo, 2016, Cancer genetics.

A case of pancreatic neuroendocrine tumors

Seijiro Sato, Y. Saijo, H. Aoyama, 2015, International Cancer Conference Journal.

Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation.

T. Abe, T. Nukiwa, S. Fujimura, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

First-line gefitinib versus first-line chemotherapy by carboplatin (CBDCA) plus paclitaxel (TXL) in non-small cell lung cancer (NSCLC) patients (pts) with EGFR mutations: A phase III study (002) by North East Japan Gefitinib Study Group.

A. Gemma, Kunihiko Kobayashi, S. Oizumi, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of life with gefitinib in patients with EGFR-mutated non-small cell lung cancer: quality of life analysis of North East Japan Study Group 002 Trial.

A. Gemma, S. Morita, Kunihiko Kobayashi, 2012, The oncologist.

Randomized phase II trial of weekly paclitaxel combined with carboplatin versus standard paclitaxel combined with carboplatin for elderly patients with advanced non-small-cell lung cancer.

M. Maemondo, T. Nukiwa, T. Ishida, 2010, Annals of Oncology.

Pharmacokinetic analysis of combination chemotherapy with carboplatin and etoposide in small-cell lung cancer patients undergoing hemodialysis.

T. Suzuki, M. Maemondo, T. Nukiwa, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells.

A. Nakamura, D. Koinuma, Kenichi Akiyama, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Randomized, phase II trial comparing amrubicin with topotecan in patients (pts) with previously treated small cell lung cancer (SCLC)

F. Hommura, K. Yamazaki, M. Maemondo, 2008 .

Mesenchymal Stromal Cells Promote Tumor Growth through the Enhancement of Neovascularization

H. Kijima, Ruowen Sun, A. Umezawa, 2011, Molecular medicine.

Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002).

A. Gemma, S. Morita, Kunihiko Kobayashi, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Suppression of surfactant protein A by an epidermal growth factor receptor tyrosine kinase inhibitor exacerbates lung inflammation

H. Xin, M. Maemondo, T. Nukiwa, 2008, Cancer science.

Adenocarcinoma with epidermal growth factor receptor gene mutations in three siblings.

T. Nukiwa, S. Sugawara, A. Inoue, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Expression of the 37-kDa laminin binding protein in murine lung tumor cell correlates with tumor angiogenesis.

T. Abe, T. Nukiwa, M. Abe, 2000, Cancer letters.

Prospective analysis of the epidermal growth factor receptor gene mutations in non-small cell lung cancer in Japan.

S. Suzuki, T. Nukiwa, T. Kondo, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations.

M. Maemondo, T. Nukiwa, Takuji Suzuki, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adenovirus vector-mediated in vivo gene transfer of OX40 ligand to tumor cells enhances antitumor immunity of tumor-bearing hosts.

K. Sugamura, M. Maemondo, T. Nukiwa, 2004, Cancer research.

Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy.

Toshikazu Nakamura, M. Maemondo, M. Tahara, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

Myelosuppression by chemotherapy in obese patients with gynecological cancers

Y. Saijo, Y. Matsumoto, Qiliang Zhou, 2016, Cancer Chemotherapy and Pharmacology.

Treatments and outcomes of older patients with esophageal cancer: Comparison with younger patients

K. Kimura, Y. Saijo, Y. Matsumoto, 2019, Molecular and clinical oncology.

The Prognostic Nutrition Index Predicts the Development of Hematological Toxicities in and the Prognosis of Esophageal Cancer Patients Treated with Cisplatin Plus 5-Fluorouracil Chemotherapy

Y. Saijo, Y. Matsumoto, Qiliang Zhou, 2018, Nutrition and cancer.

Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model.

H. Xin, Ruowen Sun, T. Nukiwa, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Analysis of Tumor-Stromal Interaction Induction of Angiogenic Factors: In Vivo Tumor Growth of Lewis Lung Carcinoma by Promotes b Proinflammatory Cytokine IL-1

T. Kikuchi, Takuji Suzuki, Masashi Tanaka, 2002 .

Exogenous recombinant human IL-12 augments MHC class I antigen expression on human cancer cells in vitro.

T. Nukiwa, Y. Saijo, K. Satoh, 1998, The Tohoku journal of experimental medicine.

Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells

Huqun, T. Honjo, H. Xin, 2005, European journal of immunology.

IgG reactive to CTL-directed epitopes of self-antigens is either lacking or unbalanced in atopic dermatitis patients.

T. Nukiwa, S. Shichijo, K. Itoh, 2003, Tissue antigens.

Non-mutated tumor-rejection antigen peptides elicit type-I allergy in the majority of healthy individuals.

T. Nukiwa, S. Shichijo, K. Itoh, 2002, Tissue antigens.

Autologous high-killing cytotoxic T lymphocytes against human lung cancer are induced using interleukin (IL)-1beta, IL-2, IL-4, and IL-6: possible involvement of dendritic cells.

K. Koike, K. Saijo, T. Ohno, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Intratracheal Delivery of CX3CL1-Expressing Mesenchymal Stem Cells to Multiple Lung Tumors

H. Mizuguchi, H. Xin, Ruowen Sun, 2009, Molecular medicine.

Consensus statement for the diagnosis and treatment of drug-induced lung injuries.

M. Kusumoto, K. Kubo, Y. Sugiyama, 2013, Respiratory investigation.

A Phase I Study of Amrubicin Combined with Carboplatin for Elderly Patients with Small-Cell Lung Cancer

M. Nishimura, K. Yamazaki, M. Maemondo, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Expansion of human autologous cytotoxic T lymphocytes on fixed target tumor cells

N. Nomura, M. Matsumura, K. Saijo, 1998, Cytotechnology.

Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors

H. Mizuguchi, T. Hayakawa, H. Xin, 2006, European journal of immunology.

Involvement of Fractalkine/CX3CL1 Expression by Dendritic Cells in the Enhancement of Host Immunity against Legionella pneumophila

T. Honjo, H. Xin, T. Nukiwa, 2005, Infection and Immunity.

N-terminal deletion augments the cell-death-inducing activity of BAX in adenoviral gene delivery to nonsmall cell lung cancers

M. Maemondo, T. Nukiwa, S. Ohta, 2003, Oncogene.

A case of severe hepatotoxicity induced by cisplatin and 5-fluorouracil

Y. Saijo, A. Toyama, Y. Tani, 2019, International Cancer Conference Journal.

Enhancement of Warfarin Anticoagulant Activity by S-1

M. Hayakari, Y. Saijo, J. Sato, 2011 .

Multicenter phase I/II study of chemoradiotherapy with high-dose CDDP for head and neck squamous cell carcinoma in Japan.

Takeshi Takahashi, A. Horii, M. Tomita, 2018, Auris, nasus, larynx.

Mesenchymal stromal cells protect cancer cells from ROS-induced apoptosis and enhance the Warburg effect by secreting STC1.

D. Prockop, M. Ebina, T. Nukiwa, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

Human T-cell lymphotropic virus type I (HTLV-I) carrier with clinical manifestations characteristic of diffuse panbronchiolitis.

T. Abe, T. Nukiwa, Y. Saijo, 1996, Internal medicine.

Increased levels of mitochondrial DNA in an etoposide-resistant human monocytic leukaemia cell line (THP-1/E).

M. Motomiya, Y. Saijo, Y. Tokue, 1991, European journal of cancer.

Characterization of resistance to VP-16 in human leukemic cell line.

M. Motomiya, Y. Saijo, Y. Tokue, 1989, The Tohoku journal of experimental medicine.

Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth.

R. Strieter, M. Kuwano, M. Ono, 2005, The Journal of clinical investigation.

Targeted Delivery of CX3CL1 to Multiple Lung Tumors by Mesenchymal Stem Cells

H. Mizuguchi, T. Hayakawa, H. Xin, 2007, Stem cells.

Multifunctional interleukin‐1β promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion‐, invasion‐ and angiogenesis‐related molecules

Akihiko Yamamoto, Hirohisa Ogawa, S. Sone, 2003, Cancer science.

Expression of nucleolar protein p120 predicts poor prognosis in patients with stage I lung adenocarcinoma.

T. Kondo, T. Nukiwa, M. Sagawa, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic value of nucleolar protein p120 in patients with resected lung adenocarcinoma.

K. Koike, T. Nukiwa, M. Sagawa, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Methylation of the KEAP1 gene promoter region in human colorectal cancer

H. Kijima, K. Itoh, Ruowen Sun, 2012, BMC Cancer.

Severe acute interstitial pneumonia and gefitinib

M. Ebina, M. Maemondo, T. Nukiwa, 2003, The Lancet.

Gene transfer of thromboxane A(2) synthase and prostaglandin I(2) synthase antithetically altered tumor angiogenesis and tumor growth.

M. Maemondo, T. Nukiwa, Masashi Tanaka, 2002, Cancer research.

Proinflammatory Cytokine IL-1β Promotes Tumor Growth of Lewis Lung Carcinoma by Induction of Angiogenic Factors: In Vivo Analysis of Tumor-Stromal Interaction1

Kazuhiro Usui, Kouji Matsushima, Makoto Miki, 2002, The Journal of Immunology.

Replication‐deficient adenovirus‐mediated transfer of B7‐1 (CD80) cDNA induces anti‐tumour immunity in isolated human lung cancer

Y. Fukuchi, M. Azuma, Y. Saijo, 2001, Respirology.

A change in the number of CCSP(pos)/SPC(pos) cells in mouse lung during development, growth, and repair.

H. Kijima, Ruowen Sun, T. Nukiwa, 2013, Respiratory investigation.

Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells

K. Matsumoto, T. Nakamura, H. Mizuguchi, 2007, Cancer Gene Therapy.

Differentiation of Mouse Induced Pluripotent Stem Cells Into Alveolar Epithelial Cells In Vitro for Use In Vivo

Y. Ajioka, Ruowen Sun, Y. Saijo, 2014, Stem cells translational medicine.

Induced pluripotent stem cells for trachea engineering

Y. Saijo, Qiliang Zhou, 2021, iPSCs in Tissue Engineering.

Phase II Study of Gefitinib Readministration in Patients with Advanced Non-Small Cell Lung Cancer and Previous Response to Gefitinib

M. Nishimura, H. Dosaka-akita, S. Oizumi, 2011, Oncology.

Efficacy of BRAF inhibitor and anti-EGFR antibody in colorectal neuroendocrine carcinoma

Shujiro Okuda, K. Yoshihara, T. Wakai, 2022, Clinical Journal of Gastroenterology.

Retrospective Analysis of Acquired Resistance During the Treatment with Gefitinib in Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutations

M. Ebina, T. Nukiwa, A. Inoue, 2009 .

High Level of Vascular Endothelial Growth Factor in Hemorrhagic Pleural Effusion of Cancer

M. Ebina, T. Nukiwa, Y. Saijo, 2002, Oncology.

A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer

Kunihiko Kobayashi, M. Tsuchida, H. Miyazawa, 2017, PloS one.

actors associated with a poor response to gefitinib in the NEJ 002 tudy : Smoking and the L 858 R mutation

I. Kinoshita, Y. Saijo, atsuro Fukuharaa, 2015 .

Efficacy of chemotherapy after first-line gefitinib therapy in EGFR mutation-positive advanced non-small cell lung cancer-data from a randomized Phase III study comparing gefitinib with carboplatin plus paclitaxel (NEJ002).

A. Gemma, Kunihiko Kobayashi, S. Oizumi, 2015, Japanese journal of clinical oncology.

Factors associated with a poor response to gefitinib in the NEJ002 study: smoking and the L858R mutation.

A. Gemma, S. Morita, Kunihiko Kobayashi, 2015, Lung cancer.

Low-Dose Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations

A. Gemma, Kunihiko Kobayashi, S. Oizumi, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

MicroRNAs control eyelid development through regulating Wnt signaling

R. Takagi, R. Hindges, J. Blackburn, 2019, Developmental dynamics : an official publication of the American Association of Anatomists.

Trachea Engineering Using a Centrifugation Method and Mouse-Induced Pluripotent Stem Cells.

Y. Ajioka, Y. Saijo, Y. Matsumoto, 2018, Tissue engineering. Part C, Methods.

Administration of wild-type p53 adenoviral vector synergistically enhances the cytotoxicity of anti-cancer drugs in human lung cancer cells irrespective of the status of p53 gene.

T. Nukiwa, S. Sugawara, A. Inoue, 2000, Cancer letters.

Identification of a CTL‐directed epitope encoded by an intron of the putative tumor suppressor gene Testin of the common fragile site 7G region: a peptide vaccine candidate for HLA‐B52+ and HLA‐62+ cancer patients

T. Nukiwa, S. Shichijo, K. Itoh, 2003, European journal of immunology.

OX40 ligand expressed by DCs costimulates NKT and CD4+ Th cell antitumor immunity in mice.

K. Sugamura, M. Taniguchi, K. Kawakami, 2007, The Journal of clinical investigation.

Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trial.

M. Narabayashi, S. Takenoshita, T. Kamoto, 2008, Japanese journal of clinical oncology.